{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:55:23Z","timestamp":1768679723327,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Portuguese Agency for Scientific Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejpb.2020.08.015","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T11:47:02Z","timestamp":1597924022000},"page":"177-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment"],"prefix":"10.1016","volume":"155","author":[{"given":"Jo\u00e3o","family":"Basso","sequence":"first","affiliation":[]},{"given":"Maria","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Jessica","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Sereno","sequence":"additional","affiliation":[]},{"given":"T\u00e2nia","family":"Cova","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Castelo-Branco","sequence":"additional","affiliation":[]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Pais","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.08.015_b0005","doi-asserted-by":"crossref","first-page":"iv1-iv86","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejpb.2020.08.015_b0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","article-title":"Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas","volume":"64","author":"Ohgaki","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejpb.2020.08.015_b0015","doi-asserted-by":"crossref","unstructured":"D.N. Louis, A. Perry, G. Reifenberger, A. Von Deimling, D. Figarella-Branger, W.K. Cavenee, H. Ohgaki, O.D. Wiestler, P. Kleihues, D.W. Ellison, The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol., 131 (2016) 803\u2013820.","DOI":"10.1007\/s00401-016-1545-1"},{"key":"10.1016\/j.ejpb.2020.08.015_b0020","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastoma","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejpb.2020.08.015_b0025","first-page":"6713","article-title":"Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms","volume":"61","author":"Zlatescu","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2020.08.015_b0030","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","author":"Davis","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ejpb.2020.08.015_b0035","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1158\/1078-0432.CCR-09-0715","article-title":"IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas","volume":"15","author":"Nobusawa","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejpb.2020.08.015_b0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2020.08.015_b0045","doi-asserted-by":"crossref","unstructured":"M. Mendes, A. Miranda, T. Cova, L. Goncalves, A.J. Almeida, J.J. Sousa, M.L. do Vale, E.F. Marques, A. Pais, C. Vitorino, Modeling of ultra-small lipid nanoparticle surface charge for targeting glioblastoma, Eur. J. Pharm. Sci., 117 (2018) 255\u2013269.","DOI":"10.1016\/j.ejps.2018.02.024"},{"key":"10.1016\/j.ejpb.2020.08.015_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2016.02.026","article-title":"Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art","volume":"227","author":"Karim","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.015_b0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/gels4030062","article-title":"Hydrogel-based drug delivery nanosystems for the treatment of brain tumors","volume":"4","author":"Basso","year":"2018","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2020.08.015_b0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.08.015_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113774","article-title":"Hierarchical design of hyaluronic acid-peptide constructs for glioblastoma targeting: combining insights from NMR and molecular dynamics simulations","volume":"315","author":"Mendes","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2020.08.015_b0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/cam.2.3.6320","article-title":"Role of hyaluronan in glioma invasion","volume":"2","author":"Park","year":"2008","journal-title":"Cell Adhesion Migrat."},{"key":"10.1016\/j.ejpb.2020.08.015_b0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.addr.2015.11.015","article-title":"Polysaccharide-based nanoparticles for theranostic nanomedicine","volume":"99","author":"Swierczewska","year":"2016","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ejpb.2020.08.015_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(03)00295-5","article-title":"Controlled targeting of liposomal doxorubicin via the folate receptor in vitro","volume":"92","author":"Saul","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.015_b0085","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1021\/nn402662d","article-title":"Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier","volume":"7","author":"Miura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2020.08.015_b0090","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.biomaterials.2011.11.078","article-title":"The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel","volume":"33","author":"Zhao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2020.08.015_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2015.12.006","article-title":"Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity","volume":"222","author":"Zhao","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.015_b0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.addr.2015.11.011","article-title":"Hyaluronic acid for anticancer drug and nucleic acid delivery","volume":"97","author":"Dosio","year":"2016","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ejpb.2020.08.015_b0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.canlet.2012.07.002","article-title":"Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer","volume":"334","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejpb.2020.08.015_b0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2018.04.039","article-title":"Repurposing drugs for glioblastoma: From bench to bedside","volume":"428","author":"Basso","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejpb.2020.08.015_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119661","article-title":"Biomimeting ultra-small lipid nanoconstructs for glioblastoma treatment: a computationally guided experimental approach","volume":"587","author":"Mendes","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.015_b0125","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1039\/C8AY01695J","article-title":"Analytical Quality by Design (AQbD) as a multiaddressable platform for co-encapsulating drug assays","volume":"10","author":"Basso","year":"2018","journal-title":"Anal. Methods"},{"key":"10.1016\/j.ejpb.2020.08.015_b0130","doi-asserted-by":"crossref","first-page":"e24438","DOI":"10.1371\/journal.pone.0024438","article-title":"Effects of Transport Inhibitors on the Cellular Uptake of Carboxylated Polystyrene Nanoparticles in Different Cell Lines","volume":"6","author":"dos Santos","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2020.08.015_b0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","article-title":"Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway","volume":"430","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.015_b0140","article-title":"NCL Method ITA-1 Analysis of Hemolytic Properties of","author":"Neun","year":"2005","journal-title":"Nanoparticles"},{"key":"10.1016\/j.ejpb.2020.08.015_b0150","unstructured":"E. Commission, Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes, Off. J. Eur. Union, 276 (2010) 33\u201379."},{"key":"10.1016\/j.ejpb.2020.08.015_b0155","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/dmd.114.057968","article-title":"Differential effects of Rifampin and Ketoconazole on the blood and liver concentration of atorvastatin in wild-type and Cyp3a and Oatp1a\/b knockout mice","volume":"42","author":"Chang","year":"2014","journal-title":"Drug Metab. Disposition"},{"key":"10.1016\/j.ejpb.2020.08.015_b0160","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.4049\/jimmunol.173.12.7641","article-title":"Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand Black\/White F1 mice","volume":"173","author":"Lawman","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejpb.2020.08.015_b0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jchromb.2014.08.009","article-title":"A validated LC-MS\/MS method for quantitative analysis of curcumin in mouse plasma and brain tissue and its application in pharmacokinetic and brain distribution studies","volume":"969","author":"Ramalingam","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejpb.2020.08.015_b0170","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.biomaterials.2010.04.062","article-title":"The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation","volume":"31","author":"Mohanty","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2020.08.015_b0175","doi-asserted-by":"crossref","first-page":"e4621","DOI":"10.1002\/bmc.4621","article-title":"Development and full validation of an HPLC methodology to quantify atorvastatin and curcumin after their intranasal co-delivery to mice","volume":"33","author":"Silva","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejpb.2020.08.015_b0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2017.08.019","article-title":"Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection","volume":"264","author":"Bastiancich","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.015_b0185","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2020.08.015_b0190","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/ar300031y","article-title":"Physicochemical properties determine nanomaterial cellular uptake, transport, and fate","volume":"46","author":"Zhu","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejpb.2020.08.015_b0195","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejpb.2020.08.015_b0200","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1021\/ic301050v","article-title":"Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles","volume":"51","author":"Yu","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejpb.2020.08.015_b0205","doi-asserted-by":"crossref","first-page":"e0151587","DOI":"10.1371\/journal.pone.0151587","article-title":"High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort","volume":"11","author":"Clarke","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2020.08.015_b0210","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1208\/s12249-018-1078-0","article-title":"Unstructured formulation data analysis for the optimization of lipid nanoparticle drug delivery vehicles","volume":"19","author":"Silva","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2020.08.015_b0215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1148\/radiology.199.2.8668788","article-title":"Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS","volume":"199","author":"Lu","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.ejpb.2020.08.015_b0220","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbacli.2016.04.002","article-title":"Magnetic resonance spectroscopy - Revisiting the biochemical and molecular milieu of brain tumors","volume":"5","author":"Verma","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.ejpb.2020.08.015_b0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/B:NERE.0000010462.72557.6d","article-title":"Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study","volume":"29","author":"Bianchi","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejpb.2020.08.015_b0230","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2020.08.015_b0235","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3171\/jns.1990.72.4.0610","article-title":"Quantitative analysis of glutathione in human brain tumors","volume":"72","author":"Kudo","year":"1990","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejpb.2020.08.015_b0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jnc.14250","article-title":"Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis","volume":"144","author":"Zhu","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejpb.2020.08.015_bib241","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijbiomac.2018.11.024","article-title":"Polymeric nanoengineered HBsAg DNA vaccine designed in combination with \u03b2\u2011glucan","volume":"122","author":"Soares","year":"2019","journal-title":"International Journal of Biological Macromolecules"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120302587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120302587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:39:35Z","timestamp":1760546375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120302587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":47,"alternative-id":["S0939641120302587"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.08.015","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}